Unrecognized hepatic steatosis and non-alcoholic steatohepatitis in adjuvant tamoxifen for breast cancer patients. [electronic resource]
Producer: 20001130Description: 1299-304 p. digitalISSN:- 1021-335X
- Adult
- Aged
- Aged, 80 and over
- Alanine Transaminase -- blood
- Antineoplastic Agents, Hormonal -- adverse effects
- Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
- Aspartate Aminotransferases -- blood
- Body Mass Index
- Breast Neoplasms -- complications
- Breast Neoplasms, Male -- complications
- Chemical and Drug Induced Liver Injury -- diagnosis
- Cholesterol -- blood
- Cyclophosphamide -- administration & dosage
- Diagnosis, Differential
- Doxorubicin -- administration & dosage
- Fatty Liver -- chemically induced
- Female
- Fluorouracil -- administration & dosage
- Humans
- Male
- Middle Aged
- Neoadjuvant Therapy
- Tamoxifen -- adverse effects
- Triglycerides -- blood
No physical items for this record
Publication Type: Clinical Trial; Journal Article
There are no comments on this title.
Log in to your account to post a comment.